Poly Medicure Limited (NSE:POLYMED)
1,899.10
-11.70 (-0.61%)
At close: Dec 5, 2025
Poly Medicure Market Cap
Poly Medicure has a market cap or net worth of 192.54 billion as of December 5, 2025. Its market cap has decreased by -27.40% in one year.
Market Cap
192.54B
Enterprise Value
184.11B
Revenue
17.12B
Ranking
n/a
PE Ratio
53.19
Stock Price
1,899.10
Market Cap Chart
Since November 19, 2004, Poly Medicure's market cap has increased from 324.00M to 192.54B, an increase of 59,326.64%. That is a compound annual growth rate of 35.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 192.54B | -27.18% |
| Dec 31, 2024 | 264.42B | 84.87% |
| Dec 29, 2023 | 143.03B | 66.54% |
| Dec 30, 2022 | 85.89B | -6.43% |
| Dec 31, 2021 | 91.79B | 105.04% |
| Dec 31, 2020 | 44.77B | 132.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.33T |
| Divi's Laboratories | 1.71T |
| Cipla | 1.23T |
| Apollo Hospitals Enterprise | 1.04T |
| Zydus Lifesciences | 941.58B |
| Mankind Pharma | 910.67B |
| Aurobindo Pharma | 702.13B |
| Fortis Healthcare | 678.14B |